Showing results (341-350 of 526) with videos related to
Sort By:
Pageof 53
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 25, 2009
In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspectiveValeria Chu, Heidi J Einolf, Raymond Evers, et al.Journal of Pediatric Orthopedics|August 22, 2022
Children's Hip Predictive (CHiP) Score: A Triage Tool for Hip Dislocation in Children Referred With Suspected Hip DysplasiaEvelyn P Murphy, Catherine Howells, Olga Gallagher, et al.The American Journal of Tropical Medicine and Hygiene|August 21, 2020
Lung Ultrasound Findings Compared with Chest X-Ray Findings in Known Pulmonary Tuberculosis Patients: A Cross-Sectional Study in Lima, PeruMatthew Fentress, Cesar Ugarte-Gil, Miguel Cervantes, et al.Research Square|July 18, 2025
Chronic Pain in a Modern Virally Suppressed HIV Cohort: Associations with Comorbidities Depression and DisabilityRonald J Ellis, Robert K Heaton, J Hampton Atkinson, et al.Lancet (London, England)|March 4, 2008
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort studyJonathan Mermin, Willy Were, John Paul Ekwaru, et al.Biotechnology and Bioengineering|January 9, 2013
Pulsed electric field (PEF) as an intensification pretreatment for greener solvent lipid extraction from microalgaeMauricio D Antezana Zbinden, Belinda S M Sturm, Ryan D Nord, et al.Archives of Sexual Behavior|December 18, 2016
A Latent Class Analysis of Seroadaptation Among Gay and Bisexual MenKiffer G Card, Nathan J Lachowsky, Zishan Cui, et al.BMJ (Clinical Research Ed.)|November 15, 2011
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness studyJames G Kahn, Elliot Marseille, David Moore, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrheaJames D Campbell, David Moore, Richard Degerman, et al.The Lancet. Global Health|March 4, 2017
Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysisAna Requena-Méndez, Sheila Bussion, Edelweiss Aldasoro, et al.Pageof 53